On the other hand, the average score of KRT17, cytology and microhematuria during the first 6 months after TUR was clearly able to predict recurrence-free survival (Fig. 5C) while each marker alone did not (Fig. 5B, Suppl Fig. 5A, B). The gene discussed is KRT17; the disease is Microscopic hematuria.